BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38483337)

  • 1. Computational and Systems Biology Advances to Enable Bioagent Agnostic Signatures.
    Lin A; Torres CM; Hobbs EC; Bardhan J; Aley SB; Spencer CT; Taylor KL; Chiang T
    Health Secur; 2024; 22(2):130-139. PubMed ID: 38483337
    [No Abstract]   [Full Text] [Related]  

  • 2. Computational and Systems Biology Advances to Enable Bioagent Agnostic Signatures.
    Lin A; Torres C; Hobbs EC; Bardhan J; Aley S; Spencer CT; Taylor KL; Chiang T
    ArXiv; 2024 Feb; ():. PubMed ID: 37961741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the List: Bioagent-Agnostic Signatures Could Enable a More Flexible and Resilient Biodefense Posture Than an Approach Based on Priority Agent Lists Alone.
    Leiser OP; Hobbs EC; Sims AC; Korch GW; Taylor KL
    Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Billions for biodefense: federal agency biodefense funding, FY2009-FY2010.
    Franco C
    Biosecur Bioterror; 2009 Sep; 7(3):291-309. PubMed ID: 19772453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Federal agency biodefense funding, FY2013-FY2014.
    Sell TK; Watson M
    Biosecur Bioterror; 2013 Sep; 11(3):196-216. PubMed ID: 23906009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Billions for biodefense: Federal Agency biodefense funding, FY2006-FY2007.
    Lam C; Franco C; Schuler A
    Biosecur Bioterror; 2006; 4(2):113-27. PubMed ID: 16792479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Billions for biodefense: federal agency biodefense funding, FY2008-FY2009.
    Franco C
    Biosecur Bioterror; 2008 Jun; 6(2):131-46. PubMed ID: 18582165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Billions for biodefense: federal agency biodefense funding, FY2007-FY2008.
    Franco C; Deitch S
    Biosecur Bioterror; 2007 Jun; 5(2):117-33. PubMed ID: 17608598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Threat Agnostic Epidemiology and Surveillance in US Public Health Agencies: Future Potential and Needs.
    Adams AM; Arrazola J; Daly ER; Tompkins M
    Health Secur; 2024; 22(1):25-30. PubMed ID: 38079238
    [No Abstract]   [Full Text] [Related]  

  • 10. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006.
    Schuler A
    Biosecur Bioterror; 2005; 3(2):94-101. PubMed ID: 16000040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Federal agency biodefense funding, FY2012-FY2013.
    Franco C; Sell TK
    Biosecur Bioterror; 2012 Jun; 10(2):162-81. PubMed ID: 22691277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American biodefense industry: from emergency to nonemergence.
    Lentzos F
    Politics Life Sci; 2007 Mar; 26(1):15-23. PubMed ID: 18208342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is systems biology?
    Elgar G
    Brief Funct Genomic Proteomic; 2008 Jul; 7(4):237-8. PubMed ID: 18621799
    [No Abstract]   [Full Text] [Related]  

  • 14. Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government Agencies.
    Downie DL; Rao P; David-Ferdon C; Courtney S; Lee JS; Quiner C; MacDonald PDM; Barnes K; Fisher S; Andreadis JL; Chaitram J; Mauldin MR; Salerno RM; Schiffer J; Gundlapalli AV
    Health Secur; 2024; 22(2):85-92. PubMed ID: 38574329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development.
    Adams LG; Khare S; Lawhon SD; Rossetti CA; Lewin HA; Lipton MS; Turse JE; Wylie DC; Bai Y; Drake KL
    Vaccine; 2011 Sep; 29(41):7197-206. PubMed ID: 21651944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Federal Agency biodefense funding, FY2011-FY2012.
    Franco C; Sell TK
    Biosecur Bioterror; 2011 Jun; 9(2):117-37. PubMed ID: 21612364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Billions for biodefense: federal agency biodefense funding, FY2001-FY2005.
    Schuler A
    Biosecur Bioterror; 2004; 2(2):86-96. PubMed ID: 15225402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Federal agency biodefense funding, FY2010-FY2011.
    Franco C; Sell TK
    Biosecur Bioterror; 2010 Jun; 8(2):129-49. PubMed ID: 20569055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Federal Funding for Health Security in FY2016.
    Boddie C; Sell TK; Watson M
    Health Secur; 2015; 13(3):186-206. PubMed ID: 26042863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A curated collection of human vaccination response signatures.
    Smith KC; Chawla DG; Dhillon BK; Ji Z; Vita R; van der Leest EC; Weng JYJ; Tang E; Abid A; ; Peters B; Hancock REW; Floratos A; Kleinstein SH
    Sci Data; 2022 Nov; 9(1):678. PubMed ID: 36347894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.